Label Revision Ordered for 3 Beta Blockers to Delete Contraindication in Pregnant Women

April 10, 2024
The Ministry of Health, Labor and Welfare (MHLW) on April 9 ordered label revisions for three beta blockers including bisoprolol fumarate (brand name: Mitsubishi Tanabe Pharma’s Maintate). Up to now, these drugs have been contraindicated in pregnant women or women...read more